To determine whether TIPRL involved in stemness and anticancer drug resistance as a target for eliminating lung CSCs, we examined its expression in lung cancer tissues, including lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), and small cell lung cancer (SCLC). Here, TIPRL is linked to lung cancer.